Inovio Pharmaceuticals
INO
#9180
Rank
NZ$0.19 B
Marketcap
NZ$2.80
Share price
3.87%
Change (1 day)
-7.58%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): NZ-$4.80

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$5.01. In 2024 the company made an earnings per share (EPS) of NZ-$6.87 an increase over its 2023 EPS that were of NZ-$10.60.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.80-30.1%
2024NZ-$6.87-35.14%
2023NZ-$10.60-56.62%
2022NZ-$24.43-19.54%
2021NZ-$30.3635.9%
2020NZ-$22.34-11.57%
2019NZ-$25.2615.24%
2018NZ-$21.92-2.78%
2017NZ-$22.556.93%
2016NZ-$21.09134.88%
2015NZ-$8.98-29.51%
2014NZ-$12.74-57.34%
2013NZ-$29.86146.55%
2012NZ-$12.1120.83%
2011NZ-$10.02-29.41%
2010NZ-$14.20-48.48%
2009NZ-$27.5610%
2008NZ-$25.0611.11%
2007NZ-$22.55-41.3%
2006NZ-$38.42-66.91%
2005NZ-$116.09110.61%
2004NZ-$55.12-61.63%
2003NZ-$143.65186.67%
2002NZ-$50.11
2001N/A-100%
2000NZ-$40.09-63.64%
1999NZ-$110.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.38-486.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.53-350.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.37-147.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.92-337.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.72-353.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.56-230.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
NZ$0.61-112.15%๐Ÿ‡บ๐Ÿ‡ธ USA